RxSight (RXST) FCF Margin (2020 - 2026)
RxSight's (RXST) quarterly FCF Margin came in at 34.07% in Q2 2026, down 1649.0% on a YoY basis from 2.2% in Q2 2025, and up 9.67% quarter-over-quarter from 37.71% in Q1 2026.
Powered by 
Analysis
RxSight (RXST) FCF Margin (2020 - 2026) Analysis & Trends
RxSight (RXST) has reported FCF Margin for 7 consecutive years, with 34.07% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 1649.0% year-over-year to 34.07%; the trailing twelve-month figure through Jun 2026 stood at 21.29% (down 709.0% YoY), and the FY2025 full-year result was 14.38%, up 162.0% from the prior year.
- FCF Margin climbed to 34.07% in Q2 2026 per RXST's latest filing, from 37.71% in the prior quarter.
- Across five years, FCF Margin topped out at 1.28% in Q3 2024 and bottomed at 171.72% in Q1 2022.
- Historically, FCF Margin has averaged 52.47% across 5 years, with a median of 36.16% in 2023.
- The sharpest annual moves came in 2022 and 2026: FCF Margin surged 13684 bps in 2022, then sank 1649 bps in 2026.
- Over 5 years, FCF Margin stood at 88.36% in 2022, then jumped by 61 bps to 34.61% in 2023, then soared by 63 bps to 12.7% in 2024, then surged by 46 bps to 6.91% in 2025, then slumped by 393 bps to 34.07% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 34.07%, 37.71%, and 6.91% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.73% |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | -34.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.07% |
| Mar 31, 2026 | -37.71% |
| Dec 31, 2025 | -6.91% |
| Sep 30, 2025 | -5.83% |
| Jun 30, 2025 | -17.58% |
| Mar 31, 2025 | -24.82% |
| Dec 31, 2024 | -12.70% |
| Sep 30, 2024 | -1.28% |
| Jun 30, 2024 | -15.91% |
| Mar 31, 2024 | -38.21% |
| Dec 31, 2023 | -34.61% |
| Sep 30, 2023 | -38.90% |
| Jun 30, 2023 | -45.02% |
| Mar 31, 2023 | -105.84% |
| Dec 31, 2022 | -88.36% |
| Sep 30, 2022 | -124.99% |
| Jun 30, 2022 | -140.00% |
| Mar 31, 2022 | -171.72% |
| Dec 31, 2021 | -107.84% |
| Sep 30, 2021 | -242.12% |